Every week our machine elves read every new psychedelic science paper on PubMed, every new preprint (via Europe PMC) and every trial registration on ClinicalTrials.gov. An editor picks the few that matter and says plainly how strong the evidence is: animal or human, controlled or not, peer reviewed or preprint.
The Science section has three parts: this week's issue, a searchable library of everything our machine elves have collected, and a research chat that answers questions from the literature and cites its sources.
This week: 5-MeO-DMT depression trial lands in JAMA
Its pitch is short in-clinic time; its control arm is a low dose, not a placebo.
